Product Information
TRIAMCINOLONE ACET 400 MG/10 ML is a generic product labeled by Mylan Institutional LLC, priced at $4.7820 per ML under NDC 67457062310. Its NADAC has been published 170 times since Jul 5, 2023.
FDA first approved this application on Nov 2, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/10mL
Manufacturer
Mylan Institutional LLCNDC
67457062310
Classification
Generic
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212567FDA Approved
11/2/2022
TE Code
AB
On Market Since
5/8/2023
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has been published 170 times since Jul 5, 2023, and over the history we have for it it has risen 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7820 per ML |
|---|---|
| All-time high | $5.3839 (May 13, 2026) |
| All-time low | $3.2942 (Feb 21, 2024) |
| 52-week high | $5.3839 |
| 52-week low | $4.4848 |
| Median price | $4.1986 |
| Average price | $4.2481 |
| Largest weekly change | +27.6% (Nov 22, 2023) |
| Weeks tracked | 170 |
| Tracking since | Jul 5, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TRIAMCINOLONE ACETONIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Institutional LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRIAMCINOLONE ACETONIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE ACET 400 MG/10 ML?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE ACET 400 MG/10 ML, manufactured by Mylan Institutional LLC, is $4.7820 per ML (NDC 67457062310), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE ACET 400 MG/10 ML changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has risen 31.5%. It has been tracked across 170 weekly CMS publications since Jul 5, 2023.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE ACET 400 MG/10 ML?
Since Jul 5, 2023, the NADAC for TRIAMCINOLONE ACET 400 MG/10 ML has ranged from a low of $3.2942 (Feb 21, 2024) to a high of $5.3839 (May 13, 2026), with a median of $4.1986 per ML.
Are there cheaper alternatives to TRIAMCINOLONE ACET 400 MG/10 ML?
No other NADAC-published product currently shares the active ingredient and strength of TRIAMCINOLONE ACET 400 MG/10 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIAMCINOLONE ACET 400 MG/10 ML?
TRIAMCINOLONE ACET 400 MG/10 ML (NDC 67457062310) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.